Hq Spclt Pharma patent expiration
1. Calcium Gluconate In Sodium Chloride patent expiration
| Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US10342813 | HQ SPCLT PHARMA | Calcium gluconate solutions in flexible containers |
Jul, 2037
(12 years from now) | |
| US10130646 | HQ SPCLT PHARMA | Calcium gluconate solutions in flexible containers |
Jul, 2037
(12 years from now) | |
Drugs and Companies using CALCIUM GLUCONATE ingredient
Market Authorisation Date: 29 October, 2018
Treatment: NA
Dosage: SOLUTION
More Information on Dosage
CALCIUM GLUCONATE IN SODIUM CHLORIDE family patents
2. Dexmedetomidine Hydrochloride patent expiration
| Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US9649296 | HQ SPCLT PHARMA | Heat sterilizeable, premixed, ready to use dexmedetomidine solution packaged in a flexible plastic container |
Apr, 2036
(11 years from now) | |
| US9717796 | HQ SPCLT PHARMA | Heat sterilizeable, premixed, ready to use dexmedetomidine solution packaged in a flexible plastic container |
Apr, 2036
(11 years from now) | |
Drugs and Companies using DEXMEDETOMIDINE HYDROCHLORIDE ingredient
Market Authorisation Date: 21 October, 2015
Treatment: NA
Dosage: SOLUTION
More Information on Dosage
DEXMEDETOMIDINE HYDROCHLORIDE family patents
3. Esmolol Hydrochloride Double Strength In Plastic Container patent
expiration
ESMOLOL HYDROCHLORIDE DOUBLE STRENGTH IN PLASTIC CONTAINER IPR and PTAB Proceedings
| Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US6528540 | HQ SPCLT PHARMA | Esmolol formulation |
Jan, 2021
(3 years ago) | |
| US6310094 | HQ SPCLT PHARMA | Ready-to-use esmolol solution |
Jan, 2021
(3 years ago) | |
|
US6528540 (Pediatric) | HQ SPCLT PHARMA | Esmolol formulation |
Jul, 2021
(3 years ago) | |
|
US6310094 (Pediatric) | HQ SPCLT PHARMA | Ready-to-use esmolol solution |
Jul, 2021
(3 years ago) | |
| US8829054 | HQ SPCLT PHARMA | Ready-to-use co-solvents pharmaceutical composition in modified flexible plastic container |
Mar, 2033
(8 years from now) | |
| US8835505 | HQ SPCLT PHARMA | Ready-to-use co-solvents pharmaceutical composition in modified flexible plastic container |
Mar, 2033
(8 years from now) | |
Drugs and Companies using ESMOLOL HYDROCHLORIDE ingredient
Market Authorisation Date: 07 April, 2016
Treatment: NA
Dosage: SOLUTION
More Information on Dosage
ESMOLOL HYDROCHLORIDE DOUBLE STRENGTH IN PLASTIC CONTAINER family patents
4. Esmolol Hydrochloride In Plastic Container patent expiration
ESMOLOL HYDROCHLORIDE IN PLASTIC CONTAINER IPR and PTAB Proceedings
| Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US6528540 | HQ SPCLT PHARMA | Esmolol formulation |
Jan, 2021
(3 years ago) | |
| US6310094 | HQ SPCLT PHARMA | Ready-to-use esmolol solution |
Jan, 2021
(3 years ago) | |
|
US6310094 (Pediatric) | HQ SPCLT PHARMA | Ready-to-use esmolol solution |
Jul, 2021
(3 years ago) | |
|
US6528540 (Pediatric) | HQ SPCLT PHARMA | Esmolol formulation |
Jul, 2021
(3 years ago) | |
| US8829054 | HQ SPCLT PHARMA | Ready-to-use co-solvents pharmaceutical composition in modified flexible plastic container |
Mar, 2033
(8 years from now) | |
| US8835505 | HQ SPCLT PHARMA | Ready-to-use co-solvents pharmaceutical composition in modified flexible plastic container |
Mar, 2033
(8 years from now) | |
Drugs and Companies using ESMOLOL HYDROCHLORIDE ingredient
Market Authorisation Date: 07 April, 2016
Treatment: NA
Dosage: SOLUTION
More Information on Dosage
ESMOLOL HYDROCHLORIDE IN PLASTIC CONTAINER family patents